Moar COVID 19 talk.

[Clyde_Style]

It is a shame that we can't talk about covid without talking about how badly it has been handled and is now turning into an ugly spectacle of political theater

I would love it if the focus could be on therapies being tested and timelines for the country and the world to regain some semblance of stability, but that's impossible under the circumstances we are facing. The world is being handicapped as long as the USA remains a superspreader nation with a president who is Exhibit A on what not to do in a pandemic

[Clyde_Style]

Conway's daughter tested positive

Claudia said that Kellyanne was walking around the house coughing without a mask.

I feel sorry for that kid. They've got the spunk to fight back and speak up, but they still have a pair of monsters for parents. Get well kid

[HarthorneWingo]

Read on Twitter

Isn't there a less specific law that would apply?

[aq_ua]

I've been looking into the Covid-19 treatment Trump is taking, as I expect this is the state of the art best treatment available today. He's taking two experimental drug treatments; Remdesivir and the lesser known Regeneron.

Remdesivir

A drug that once offered hope in the treatment of Ebola, remdesivir is an antiviral medicine that has been given "emergency use authorisation" in the US to treat patients in hospital "with severe COVID-19", but is not approved for general use.

The EU has also authorised its use for COVID-19 treatment only.

It is injected into the vein in the hope it will prevent SARS CoV-2 (the virus that causes COVID-19) from multiplying in the body, with some patients recovering faster after using it.

Gilead Sciences Inc began research on remdesivir in 2009 as part of studies into hepatitis C and respiratory syncytial virus (RSV), a common and highly contagious respiratory virus that most children get before they turn two.

Several clinical trials and laboratory studies have taken place since January, with some promising signs.

However, a report published in The Lancet medical journal on 3 October looking at several studies has found remdesivir "did not appear to affect rates of SARS CoV-2 viral load decline and mortality".

It said using remdesivir early "substantially decreased" viral loads but this effect was "completely lost" when the drug was given just eight hours after infection.

The report concluded that remdesivir "might require initiation before the peak viral replication" but that is "not feasible" in humans as they display symptoms after the virus multiplies.

Regeneron Treatment

Last weekend, the drug started being used in "about three hospitals in the north" of England as part of Oxford University's national recovery trial, Professor Peter Horby told the BBC.

The specialist in emerging infectious diseases at the University of Oxford said the drug is "very promising" and "very potent".

This class of drugs is "pretty safe and well understood" so is something he has "confidence in", he said.

He added that about four or five hundred patients have been given it so far and there have been "no worrying safety signals", with the plan to roll it out to another 30 to 40 UK hospitals next week.

Dr Jeremy Faust, an emergency doctor at Brigham and Women's Hospital in Boston, said he would not give it to his patients because he could not say what the benefit is, or the risks.

He added that giving an unproven treatment to the president "sends a message that they're scrambling".

https://news.sky.com/story/trump-coronavirus-us-president-is-taking-two-experimental-drugs-what-are-they-12088489

Although Regeneron’s product has not been authorized for emergency use by the Food and Drug Administration, companies can grant access to their experimental treatments through compassionate use, for example, if all other options have failed and a patient might die without trying the drug.

“Presidential medicine is and has been unique,” said Arthur L. Caplan, a professor of medical ethics at the N.Y.U. Grossman School of Medicine. “If his doctors think an intervention might be helpful, and if that judgment is confirmed by outside experts they talk to, and if things look dire or serious, then the president will get access to any and all agents.”

https://www.nytimes.com/2020/10/02/health/trump-antibody-treatment.html

It sounds like there is a stronger reliance on the Regeneron treatment, and everything in the description of the drugs suggests Trump's case is rather severe. It's notable that none of these treatments are FDA approved, although have passed the safety trials. The medical staff seem like they're going to fairly extensive lengths of treatment.

[aq_ua]

Read on Twitter

Isn't there a less specific law that would apply?

I suppose simply if someone were to die due to willful and knowing transmission, there could be a criminal case to be filed (involuntary manslaughter type charges). That's sort of where the HIV laws started in the US.

[Clyde_Style]

Read on Twitter

Isn't there a less specific law that would apply?

I think it would have to be highly specified. I don't have time now to research it, but there may some corollary on the books. I recall intentional HIV infections generated lawsuits, but I'm not versed on the laws

[HarthorneWingo]

Read on Twitter

Isn't there a less specific law that would apply?

I suppose simply if someone were to die due to willful and knowing transmission, there could be a criminal case to be filed (involuntary manslaughter type charges). That's sort of where the HIV laws started in the US.

Exactly what I've been thinking. Certainly, knowingly transmitting someone to a knowlingly deadly virus can't be legal.

[Clyde_Style]

I've been looking into the Covid-19 treatment Trump is taking, as I expect this is the state of the art best treatment available today. He's taking two experimental drug treatments; Remdesivir and the lesser known Regeneron.

Remdesivir

A drug that once offered hope in the treatment of Ebola, remdesivir is an antiviral medicine that has been given "emergency use authorisation" in the US to treat patients in hospital "with severe COVID-19", but is not approved for general use.

The EU has also authorised its use for COVID-19 treatment only.

It is injected into the vein in the hope it will prevent SARS CoV-2 (the virus that causes COVID-19) from multiplying in the body, with some patients recovering faster after using it.

Gilead Sciences Inc began research on remdesivir in 2009 as part of studies into hepatitis C and respiratory syncytial virus (RSV), a common and highly contagious respiratory virus that most children get before they turn two.

Several clinical trials and laboratory studies have taken place since January, with some promising signs.

However, a report published in The Lancet medical journal on 3 October looking at several studies has found remdesivir "did not appear to affect rates of SARS CoV-2 viral load decline and mortality".

It said using remdesivir early "substantially decreased" viral loads but this effect was "completely lost" when the drug was given just eight hours after infection.

The report concluded that remdesivir "might require initiation before the peak viral replication" but that is "not feasible" in humans as they display symptoms after the virus multiplies.

Regeneron Treatment

Last weekend, the drug started being used in "about three hospitals in the north" of England as part of Oxford University's national recovery trial, Professor Peter Horby told the BBC.

The specialist in emerging infectious diseases at the University of Oxford said the drug is "very promising" and "very potent".

This class of drugs is "pretty safe and well understood" so is something he has "confidence in", he said.

He added that about four or five hundred patients have been given it so far and there have been "no worrying safety signals", with the plan to roll it out to another 30 to 40 UK hospitals next week.

Dr Jeremy Faust, an emergency doctor at Brigham and Women's Hospital in Boston, said he would not give it to his patients because he could not say what the benefit is, or the risks.

He added that giving an unproven treatment to the president "sends a message that they're scrambling".

https://news.sky.com/story/trump-coronavirus-us-president-is-taking-two-experimental-drugs-what-are-they-12088489

Although Regeneron’s product has not been authorized for emergency use by the Food and Drug Administration, companies can grant access to their experimental treatments through compassionate use, for example, if all other options have failed and a patient might die without trying the drug.

“Presidential medicine is and has been unique,” said Arthur L. Caplan, a professor of medical ethics at the N.Y.U. Grossman School of Medicine. “If his doctors think an intervention might be helpful, and if that judgment is confirmed by outside experts they talk to, and if things look dire or serious, then the president will get access to any and all agents.”

https://www.nytimes.com/2020/10/02/health/trump-antibody-treatment.html

It sounds like there is a stronger reliance on the Regeneron treatment, and everything in the description of the drugs suggests Trump's case is rather severe. It's notable that none of these treatments are FDA approved, although have passed the safety trials. The medical staff seem like they're going to fairly extensive lengths of treatment.

Plus, the rushed attempts to appear before the public feel desperate. If he was really responding to treatment and improving then why would he need to keep putting up videos and jumping into cars? Yeah, I know, he has an abnormal psychology, but still it comes off as the actions of some banana republic, not a legit government. I think Trump will do anything to crank out content while he is sick. It doesn't mean he's well. It's just Trump being Trump.

[Clyde_Style]

Read on Twitter

[Phish Tank]

This entire article is why Dean Baquet is a clown, bothsidesim fails, the NY Times sucks, and why I've stopped reading it. (FYI - I'm only posting because other people read it and eviscerated The Times)

Read on Twitter

[HarthorneWingo]

This entire article is why Dean Baquet is a clown, bothsidesim fails, the NY Times sucks, and why I've stopped reading it. (FYI - I'm only posting because other people read it and eviscerated The Times)

Read on Twitter

I saw the headline for that article and just shook my head. I guess even The NY Times panders to the right.

[Clyde_Style]

This entire article is why Dean Baquet is a clown, bothsidesim fails, the NY Times sucks, and why I've stopped reading it. (FYI - I'm only posting because other people read it and eviscerated The Times)

Read on Twitter

I saw the headline for that article and just shook my head. I guess even The NY Times panders to the right.

The Times still breaks important stories like Trump's taxes a week ago. That matters, but I've spoken out against their bothsideisms very loudly in the past and I'm sick of it too. It doesn't mean I won't read it, but I feel like they sometimes miss the target by a mile trying to be so damn PC about managing their appearance of objectivity. I've ranted about this in the past, but simply put the purpose of non-partisan reporting should not be about giving equal time, but uncovering the truth.

[Clyde_Style]

Read on Twitter

the negligence, callousness, deflection, lack of accountability and attempt to cover-up continues

stuff like this guarantees internal rebellion and more leaks about how they covered this up. It is like Trump and everyone he attracts into his orbit are wired to self-destruct and make the pettiest and stupidest decisions possible

[Pointgod]

I've been looking into the Covid-19 treatment Trump is taking, as I expect this is the state of the art best treatment available today. He's taking two experimental drug treatments; Remdesivir and the lesser known Regeneron.

Remdesivir

A drug that once offered hope in the treatment of Ebola, remdesivir is an antiviral medicine that has been given "emergency use authorisation" in the US to treat patients in hospital "with severe COVID-19", but is not approved for general use.

The EU has also authorised its use for COVID-19 treatment only.

It is injected into the vein in the hope it will prevent SARS CoV-2 (the virus that causes COVID-19) from multiplying in the body, with some patients recovering faster after using it.

Gilead Sciences Inc began research on remdesivir in 2009 as part of studies into hepatitis C and respiratory syncytial virus (RSV), a common and highly contagious respiratory virus that most children get before they turn two.

Several clinical trials and laboratory studies have taken place since January, with some promising signs.

However, a report published in The Lancet medical journal on 3 October looking at several studies has found remdesivir "did not appear to affect rates of SARS CoV-2 viral load decline and mortality".

It said using remdesivir early "substantially decreased" viral loads but this effect was "completely lost" when the drug was given just eight hours after infection.

The report concluded that remdesivir "might require initiation before the peak viral replication" but that is "not feasible" in humans as they display symptoms after the virus multiplies.

Regeneron Treatment

Last weekend, the drug started being used in "about three hospitals in the north" of England as part of Oxford University's national recovery trial, Professor Peter Horby told the BBC.

The specialist in emerging infectious diseases at the University of Oxford said the drug is "very promising" and "very potent".

This class of drugs is "pretty safe and well understood" so is something he has "confidence in", he said.

He added that about four or five hundred patients have been given it so far and there have been "no worrying safety signals", with the plan to roll it out to another 30 to 40 UK hospitals next week.

Dr Jeremy Faust, an emergency doctor at Brigham and Women's Hospital in Boston, said he would not give it to his patients because he could not say what the benefit is, or the risks.

He added that giving an unproven treatment to the president "sends a message that they're scrambling".

https://news.sky.com/story/trump-coronavirus-us-president-is-taking-two-experimental-drugs-what-are-they-12088489

Although Regeneron’s product has not been authorized for emergency use by the Food and Drug Administration, companies can grant access to their experimental treatments through compassionate use, for example, if all other options have failed and a patient might die without trying the drug.

“Presidential medicine is and has been unique,” said Arthur L. Caplan, a professor of medical ethics at the N.Y.U. Grossman School of Medicine. “If his doctors think an intervention might be helpful, and if that judgment is confirmed by outside experts they talk to, and if things look dire or serious, then the president will get access to any and all agents.”

https://www.nytimes.com/2020/10/02/health/trump-antibody-treatment.html

It sounds like there is a stronger reliance on the Regeneron treatment, and everything in the description of the drugs suggests Trump's case is rather severe. It's notable that none of these treatments are FDA approved, although have passed the safety trials. The medical staff seem like they're going to fairly extensive lengths of treatment.

Wait no hydrochlorinique?

[Clyde_Style]

I've been looking into the Covid-19 treatment Trump is taking, as I expect this is the state of the art best treatment available today. He's taking two experimental drug treatments; Remdesivir and the lesser known Regeneron.

Remdesivir

A drug that once offered hope in the treatment of Ebola, remdesivir is an antiviral medicine that has been given "emergency use authorisation" in the US to treat patients in hospital "with severe COVID-19", but is not approved for general use.

The EU has also authorised its use for COVID-19 treatment only.

It is injected into the vein in the hope it will prevent SARS CoV-2 (the virus that causes COVID-19) from multiplying in the body, with some patients recovering faster after using it.

Gilead Sciences Inc began research on remdesivir in 2009 as part of studies into hepatitis C and respiratory syncytial virus (RSV), a common and highly contagious respiratory virus that most children get before they turn two.

Several clinical trials and laboratory studies have taken place since January, with some promising signs.

However, a report published in The Lancet medical journal on 3 October looking at several studies has found remdesivir "did not appear to affect rates of SARS CoV-2 viral load decline and mortality".

It said using remdesivir early "substantially decreased" viral loads but this effect was "completely lost" when the drug was given just eight hours after infection.

The report concluded that remdesivir "might require initiation before the peak viral replication" but that is "not feasible" in humans as they display symptoms after the virus multiplies.

Regeneron Treatment

Last weekend, the drug started being used in "about three hospitals in the north" of England as part of Oxford University's national recovery trial, Professor Peter Horby told the BBC.

The specialist in emerging infectious diseases at the University of Oxford said the drug is "very promising" and "very potent".

This class of drugs is "pretty safe and well understood" so is something he has "confidence in", he said.

He added that about four or five hundred patients have been given it so far and there have been "no worrying safety signals", with the plan to roll it out to another 30 to 40 UK hospitals next week.

Dr Jeremy Faust, an emergency doctor at Brigham and Women's Hospital in Boston, said he would not give it to his patients because he could not say what the benefit is, or the risks.

He added that giving an unproven treatment to the president "sends a message that they're scrambling".

https://news.sky.com/story/trump-coronavirus-us-president-is-taking-two-experimental-drugs-what-are-they-12088489

Although Regeneron’s product has not been authorized for emergency use by the Food and Drug Administration, companies can grant access to their experimental treatments through compassionate use, for example, if all other options have failed and a patient might die without trying the drug.

“Presidential medicine is and has been unique,” said Arthur L. Caplan, a professor of medical ethics at the N.Y.U. Grossman School of Medicine. “If his doctors think an intervention might be helpful, and if that judgment is confirmed by outside experts they talk to, and if things look dire or serious, then the president will get access to any and all agents.”

https://www.nytimes.com/2020/10/02/health/trump-antibody-treatment.html

It sounds like there is a stronger reliance on the Regeneron treatment, and everything in the description of the drugs suggests Trump's case is rather severe. It's notable that none of these treatments are FDA approved, although have passed the safety trials. The medical staff seem like they're going to fairly extensive lengths of treatment.

Wait no hydrochlorinique?

No, Trump broke his Pez dispenser

[HarthorneWingo]

This entire article is why Dean Baquet is a clown, bothsidesim fails, the NY Times sucks, and why I've stopped reading it. (FYI - I'm only posting because other people read it and eviscerated The Times)

Read on Twitter

I saw the headline for that article and just shook my head. I guess even The NY Times panders to the right.

The Times still breaks important stories like Trump's taxes a week ago. That matters, but I've spoken out against their bothsideisms very loudly in the past and I'm sick of it too. It doesn't mean I won't read it, but I feel like they sometimes miss the target by a mile trying to be so damn PC about managing their appearance of objectivity. I've ranted about this in the past, but simply put the purpose of non-partisan reporting should not be about giving equal time, but uncovering the truth.

Right, it does which I why I keep reading it but when I see these stories I'm like ...

[Clyde_Style]

WTF is Mike Pence?

This is getting really disturbing

[HarthorneWingo]

I've been looking into the Covid-19 treatment Trump is taking, as I expect this is the state of the art best treatment available today. He's taking two experimental drug treatments; Remdesivir and the lesser known Regeneron.

Remdesivir

A drug that once offered hope in the treatment of Ebola, remdesivir is an antiviral medicine that has been given "emergency use authorisation" in the US to treat patients in hospital "with severe COVID-19", but is not approved for general use.

The EU has also authorised its use for COVID-19 treatment only.

It is injected into the vein in the hope it will prevent SARS CoV-2 (the virus that causes COVID-19) from multiplying in the body, with some patients recovering faster after using it.

Gilead Sciences Inc began research on remdesivir in 2009 as part of studies into hepatitis C and respiratory syncytial virus (RSV), a common and highly contagious respiratory virus that most children get before they turn two.

Several clinical trials and laboratory studies have taken place since January, with some promising signs.

However, a report published in The Lancet medical journal on 3 October looking at several studies has found remdesivir "did not appear to affect rates of SARS CoV-2 viral load decline and mortality".

It said using remdesivir early "substantially decreased" viral loads but this effect was "completely lost" when the drug was given just eight hours after infection.

The report concluded that remdesivir "might require initiation before the peak viral replication" but that is "not feasible" in humans as they display symptoms after the virus multiplies.

Regeneron Treatment

Last weekend, the drug started being used in "about three hospitals in the north" of England as part of Oxford University's national recovery trial, Professor Peter Horby told the BBC.

The specialist in emerging infectious diseases at the University of Oxford said the drug is "very promising" and "very potent".

This class of drugs is "pretty safe and well understood" so is something he has "confidence in", he said.

He added that about four or five hundred patients have been given it so far and there have been "no worrying safety signals", with the plan to roll it out to another 30 to 40 UK hospitals next week.

Dr Jeremy Faust, an emergency doctor at Brigham and Women's Hospital in Boston, said he would not give it to his patients because he could not say what the benefit is, or the risks.

He added that giving an unproven treatment to the president "sends a message that they're scrambling".

https://news.sky.com/story/trump-coronavirus-us-president-is-taking-two-experimental-drugs-what-are-they-12088489

Although Regeneron’s product has not been authorized for emergency use by the Food and Drug Administration, companies can grant access to their experimental treatments through compassionate use, for example, if all other options have failed and a patient might die without trying the drug.

“Presidential medicine is and has been unique,” said Arthur L. Caplan, a professor of medical ethics at the N.Y.U. Grossman School of Medicine. “If his doctors think an intervention might be helpful, and if that judgment is confirmed by outside experts they talk to, and if things look dire or serious, then the president will get access to any and all agents.”

https://www.nytimes.com/2020/10/02/health/trump-antibody-treatment.html

It sounds like there is a stronger reliance on the Regeneron treatment, and everything in the description of the drugs suggests Trump's case is rather severe. It's notable that none of these treatments are FDA approved, although have passed the safety trials. The medical staff seem like they're going to fairly extensive lengths of treatment.

Wait no hydrochlorinique?

We have UV light and bleach. We don't need no stinking hydroxychloroquine.

Watch on YouTube

[Clyde_Style]

Read on Twitter

I'm bored whined the little boy, let's go for a car ride!

[HarthorneWingo]

WTF is Mike Pence?

This is getting really disturbing

You think he's got it too?